{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:28:36Z","timestamp":1792794516842,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,24]]},"abstract":"<jats:p>This study fills a gap in literature by providing contemporary real-world evidence on the prevalence of patients with gastroesophageal reflux disease (GERD), Barrett esophagus (BE), and Barrett esophagus-related neoplasia (BERN) and their upper endoscopy utilization patterns in the United States. A retrospective cohort study design was used: adults with GERD, nondysplastic Barrett esophagus (NDBE), and BERN (indefinite for dysplasia [IND], low-grade dysplasia [LGD], high-grade dysplasia [HGD], or esophageal adenocarcinoma [EAC]) were identified from the MarketScan databases (January 01, 2015\u2013December 31, 2019). For each disease stage, prevalence of adults in commercial claims by calendar year, annual number of upper endoscopies per patient and time between upper endoscopies were reported. In 2019, in commercial claims (N\u2005=\u200512,363,227), the annual prevalence rate of GERD was 13.7% and 0.70% for BE\/BERN, among which, 87.1% had NDBE, 6.8% had IND, 2.3% had LGD, 1.0% had HGD, and 2.8% had EAC. From 2015-2019, the study included 3,310,385 patients with GERD, 172,481 with NDBE, 11,516 with IND, 4332 with LGD, 1549 with HGD, and 11,676 with EAC. Annual mean number of upper endoscopies was 0.20 per patient for GERD, 0.37 per patient for NDBE, 0.43 for IND, 0.58 for LGD, and 0.87 for HGD. Median time (months) to second upper endoscopy was 38.10 for NDBE, 36.63 for IND, 22.63 for LGD, and 11.90 for HGD. Upper endoscopy utilization increased from GERD to BE to BERN, and time between upper endoscopies decreased as the disease stage progressed from BE to BERN, with less frequent utilization in BERN than what would be expected from guideline recommendations for surveillance.<\/jats:p>","DOI":"10.1097\/md.0000000000033072","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T13:11:03Z","timestamp":1679663463000},"page":"e33072","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States"],"prefix":"10.1097","volume":"102","author":[{"given":"Prateek","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Kansas School of Medicine and VA Medical Center, Kansas City, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Falk","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Bhor","sequence":"additional","affiliation":[{"name":"Exact Sciences, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Burak","family":"Ozbay","sequence":"additional","affiliation":[{"name":"Exact Sciences, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-9220","authenticated-orcid":false,"given":"Dominick","family":"Latremouille-Viau","sequence":"additional","affiliation":[{"name":"Analysis Group, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Analysis Group, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Shi","sequence":"additional","affiliation":[{"name":"Analysis Group, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Elvekrog","sequence":"additional","affiliation":[{"name":"Exact Sciences, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Limburg","sequence":"additional","affiliation":[{"name":"Exact Sciences, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gutjnl-2020-321598","article-title":"Computational modelling suggests that Barrett\u2019s oesophagus may be the precursor of all oesophageal adenocarcinomas.","volume":"70","author":"Curtius","year":"2021","journal-title":"Gut"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/wjon1254","article-title":"Esophageal cancer: an updated surveillance epidemiology and end results database analysis.","volume":"11","author":"Then","year":"2020","journal-title":"World J Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cncr.27834","article-title":"Trends in esophageal adenocarcinoma incidence and mortality.","volume":"119","author":"Hur","year":"2013","journal-title":"Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2013.72","article-title":"Age at onset of GERD symptoms predicts risk of Barrett\u2019s esophagus.","volume":"108","author":"Thrift","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archinte.164.14.1482","article-title":"Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.","volume":"164","author":"Chang","year":"2004","journal-title":"Arch Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gtc.2015.02.001","article-title":"Epidemiology of Barrett\u2019s esophagus and esophageal adenocarcinoma.","volume":"44","author":"Runge","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000445349","article-title":"Risk factors for Barrett\u2019s oesophagus.","volume":"3","author":"Sharma","year":"2016","journal-title":"Gastrointest Tumors"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","article-title":"The epidemiology of esophageal adenocarcinoma.","volume":"154","author":"Coleman","year":"2018","journal-title":"Gastroenterology"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10620-018-5161-x","article-title":"Natural history of Barrett\u2019s esophagus.","volume":"63","author":"Kuipers","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"7431850","DOI":"10.1155\/2019\/7431850","article-title":"Incidence and survival changes in patients with esophageal adenocarcinoma during 1984-2013.","volume":"2019","author":"Haiyu","year":"2019","journal-title":"Biomed Res Int"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2022.02.003","article-title":"Understanding compliance, practice patterns, and barriers among gastroenterologists and primary care providers is crucial for developing strategies to improve screening for Barrett\u2019s esophagus.","volume":"162","author":"Kolb","year":"2022","journal-title":"Gastroenterology"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrgastro.2015.24","article-title":"Precision prevention of oesophageal adenocarcinoma.","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ajg.2013.421","article-title":"Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.","volume":"109","author":"Sheikh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","article-title":"Diagnosis and management of Barrett\u2019s esophagus: an updated ACG guideline.","volume":"117","author":"Shaheen","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus.","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gie.2019.05.012","article-title":"ASGE guideline on screening and surveillance of Barrett\u2019s esophagus.","volume":"90","author":"Qumseya","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gie.2011.08.042","article-title":"Overutilization of endoscopic surveillance in nondysplastic Barrett\u2019s esophagus: a multicenter study.","volume":"75","author":"Crockett","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox080","article-title":"Frequency of endoscopic surveillance for Barrett\u2019s esophagus is influenced by health insurance status: results from a population-based analysis.","volume":"30","author":"Faqih","year":"2017","journal-title":"Dis Esophagus"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cgh.2018.01.052","article-title":"Use of appropriate surveillance for patients with nondysplastic Barrett\u2019s esophagus.","volume":"16","author":"Tavakkoli","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2019.10.022","article-title":"Utilization of surveillance endoscopy for Barrett\u2019s esophagus in medicare enrollees.","volume":"158","author":"Rubenstein","year":"2020","journal-title":"Gastroenterology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15760","article-title":"Systematic review with meta-analysis: prevalence of prior and concurrent Barrett\u2019s oesophagus in oesophageal adenocarcinoma patients.","volume":"52","author":"Tan","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s10620-018-5068-6","article-title":"Barrett\u2019s esophagus and esophageal adenocarcinoma: how common are they really?","volume":"63","author":"Thrift","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10620-009-0927-9","article-title":"GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting.","volume":"55","author":"Halpern","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0974-7788.76794","article-title":"Understanding survival analysis: Kaplan-Meier estimate.","volume":"1","author":"Goel","year":"2010","journal-title":"Int J Ayurveda Res"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2003.09.030","article-title":"Screening for Barrett\u2019s esophagus in colonoscopy patients with and without heartburn.","volume":"125","author":"Rex","year":"2003","journal-title":"Gastroenterology"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0016-5107(04)02589-1","article-title":"The frequency of Barrett\u2019s esophagus in high-risk patients with chronic GERD.","volume":"61","author":"Westhoff","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2013.11.006","article-title":"Epidemiology of gastroesophageal reflux disease.","volume":"43","author":"Rubenstein","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: a systematic review.","volume":"5","author":"El-Serag","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20250504","first-page":"e3709","article-title":"Incidence of esophageal cancer in the United States from 2001-2015: a United States cancer statistics analysis of 50 states.","volume":"10","author":"Patel","year":"2018","journal-title":"Cureus"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.gie.2017.10.011","article-title":"Endoscopic eradication therapy for patients with Barrett\u2019s esophagus-associated dysplasia and intramucosal cancer.","volume":"87","author":"Wani","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s12885-018-4620-2","article-title":"Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.","volume":"18","author":"Thein","year":"2018","journal-title":"BMC Cancer"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.3748\/wjg.v23.i28.5051","article-title":"Barrett\u2019s oesophagus: current controversies.","volume":"23","author":"Amadi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ajg.2009.159","article-title":"Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.","volume":"104","author":"Cooper","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1002\/cam4.2451","article-title":"Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.","volume":"8","author":"Tramontano","year":"2019","journal-title":"Cancer Med"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/gutjnl-2014-308865","article-title":"Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett\u2019s oesophagus.","volume":"65","author":"El-Serag","year":"2016","journal-title":"Gut"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1053\/j.gastro.2018.02.022","article-title":"The effect of endoscopic surveillance in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis.","volume":"154","author":"Codipilly","year":"2018","journal-title":"Gastroenterology"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cgh.2014.03.036","article-title":"Screening for Barrett\u2019s esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.","volume":"13","author":"Sami","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.gtc.2016.04.001","article-title":"Esophageal cancer.","volume":"45","author":"Alsop","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.gtc.2015.02.011","article-title":"Cost-analyses studies in Barrett\u2019s esophagus: what is their utility?","volume":"44","author":"Gerson","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.giec.2020.08.005","article-title":"Cost-effectiveness of screening, surveillance, and endoscopic eradication therapies for managing the burden of esophageal adenocarcinoma.","volume":"31","author":"Rubenstein","year":"2021","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.giec.2020.08.002","article-title":"Endoscopic screening for Barrett\u2019s esophagus and esophageal adenocarcinoma: rationale, candidates, and challenges.","volume":"31","author":"Kamboj","year":"2021","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.giec.2020.08.003","article-title":"Best practices in surveillance for Barrett\u2019s esophagus.","volume":"31","author":"Triggs","year":"2021","journal-title":"Gastrointest Endosc Clin N Am"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:38:07Z","timestamp":1746326287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033072","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}